Navigation Links
Decreasing insulin resistance prevents obesity-related cardiovascular damage
Date:2/11/2009

AUGUSTA, Ga. - Knocking out one gene that contributes to insulin resistance appears to prevent much of the cardiovascular damage typically associated with obesity, researchers say.

Cardiovascular disease is the biggest health threat of obesity and Medical College of Georgia researchers trying to understand why have knocked out protein tyrosine phosphatase 1B, or PTP1B, in genetically fat mice that get diabetes.

"Even before you have really bad diabetes, you are walking around obese with your glucose control a little bit off and already beating up your circulation," says Dr. David Stepp, vascular biologist at the MCG Vascular Biology Center and co-director of MCG's Diabetes & Obesity Discovery Institute. "That is the point where you need to be intervening."

If he's right, PTP1B becomes a drug target for obese people who may not yet be diabetic but already have trouble with blood glucose control.

"We have shown cardiovascular function is improved by knocking out this gene. The question is why," says Dr. Stepp, principal investigator on five-year, $2.5 million National Institutes of Health grant that he hopes will help find the answer.

He suspects resistance may again be the problem but this time it's to nitric oxide, a powerful dilator of blood vessels.

Overeating increases glucose so the body increases insulin production in an effort to use or store this important energy source. In people headed toward diabetes, the body begins to miscalculate insulin needs and overproduce; fine control is lost and the high and low insulin swings begin.

"If you are obese, the fasting glucose may be a little bit off but not terrible. What is terrible is you are beginning to lose control," says Dr. Stepp, associate professor in the MCG Schools of Medicine and Graduate Studies. Over time, the body gets in the vicious cycle of making more insulin and paying less attention to it. Blood glucose levels soar while the body
'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study shows mercury levels from products decreasing, though still at dangerous levels
2. Pesticide concentrations decreasing
3. Sugary drinks, not fruit juice, may be linked to insulin
4. Drug could improve pregnancy outcomes in wider range of women with insulin resistance
5. Botched production of insulin molecule may lead to diabetes
6. Insulins brain impact links drugs and diabetes
7. Bypassing the insulin highway
8. A single mechanism for hypertension, insulin resistance and immune suppression
9. Trans-fatty acids and insulin sensitivity
10. Treatment corrects severe insulin imbalance in animal studies
11. UNC scientists turn human skin cells into insulin-producing cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...a hormone produced in the stomach, may be used to ...arkinson,s disease, Yale School of Medicine resear...e of the Journal of Neuroscience . , Parkinson,...neurons in an area of the midbrain known as the su...production. Reduced production of dopamine in lat...
(Date:11/25/2009)...WI, NOVEMBER 25, 2009 Soil is the linchpin of the...rosphere meet. Despite that, many students see soi...ing more. Soil science educators are challenged wi...ognize the critical importance of soil in the envi...nce and earth science teachers at University of Ne...
(Date:11/24/2009)...ands of years it has been prescribed by traditiona...rom headaches and stomach pain to fever and flu. ,... University have been able to scientifically prove... otherwise known as Brazilian mint. , Testing th...ed by researcher Graciela Rocha was able to show t...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2Tyco International to Present at the Citi Industrial Manufacturing 26amp 3B Transportation Conference 60962 1Perrigo Company to Present at the Credit Suisse 18th Annual Health Care Conference 60960 1BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to 24665 Million 14767 1BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to 24665 Million 14767 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to 24665 Million 14767 3
...sonings are rare but on the riseand infants are th... of Georgia study that aims to raise awareness of ...linical professor in the UGA College of Pharmacy, ...ears of recent federal mortality data and identifi...hat corresponds to a rate of 0.26 poisonings per m...
...h & Science University researchers, along with sci... uncovering new information about the mind by stud... this research will one day provide new tools for ...the progress of treatments. The researchers, lates...c Library of Science Computational Biology . , "F...
...y of Liverpool have been awarded 1.7 million to in...ove the effectiveness of pharmaceutical drugs. , ... at sizes close to molecular level to produce part...llaborative project between the Departments of Che...techniques to develop new approaches for future dr...
Other Biology News:Study finds homicidal poisoning rising, more likely in infants and elderly 2OHSU researchers study the idling brain 2University awarded £1.7M to develop nanotechnology for use in health care 2
(Date:11/24/2009)... available in German . , Whether it,s CD pa...tags (Radio Frequency Identification) are increasi...ke it possible to label objects or goods and ident...ropriate scanner can read and process the data con...o goods under production conditions of up to 100 d...
(Date:11/24/2009)...BLENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/--Dow...setsofHylandSeeds,adivisionofThompsonsLimitedofBle...xpandDowAgroSciences,currentseedsbusinessasthecomp...2010 andDowAgroSciencesHerbicideTolerantTraitTech...inthenearfuture. ,, "Thisacquisitionbringstoget...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--NODPharmaceuticalsInc.anno...edthepatentapplicationfor,itsnano-particleoraldeli...efficientapproachtoincorporatepeptidesor,proteinsi...fdrugs,otherwiseadministeredasinjections.NODtechno...cromoleculardrugssuchasinsulin,interferon,growthh...
(Date:11/24/2009)...icacyendpointhasbeenmetforpatientswithadvanced-sta...,Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc.(...rmaceuticalcompanyfocusedonendocrinetherapyandonco...studywithitstargetedcytotoxicpeptideconjugate,AEZS...rentendometrialcancer.Inapersonalizedhealthcareapp...
Breaking Biology Technology:Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
... Nile Therapeutics, Inc.,(Nasdaq: NLTX ), today ...cer,of Nile, will present at the Rodman & Renshaw ....m. CET on Tuesday, May 20th at Le Meridian Beach,...ll provide a company,overview and update on the st...ms., The presentation will be webcast live and ca...
...lumbia and SAN DIEGO, May 13 ,Adnavance Technologi...,diagnostic tests for medical applications, announ...e, Ph.D., to its Scientific Advisory Board. Dr.,Va...spects of product,development, including design, v...for medical and diagnostic devices., Dr. Valcke c...
...Phase 2 Trials Underway, MONTVALE, N.J., May 13 ... the first patient in a 160-patient Phase 2 study,...lure. BREAK (Beginning a,Randomized Evaluation of ...r Alagebrium in Diastolic Heart Failure) is a rand...ssess the effect of six months,of oral treatment w...
Other Biology Technology:Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2Adnavance Technologies Inc. Appoints Christian P. Valcke, Ph.D., to Its Scientific Advisory Board 2Adnavance Technologies Inc. Appoints Christian P. Valcke, Ph.D., to Its Scientific Advisory Board 3Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 2Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 3Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 4
Random DNA mutagenesis Service from Yorkshire Bioscience Ltd
...ated solution for scheduling, performing and docum...sting for all pipettes and liquid handling devices...pports all gravimetric calibration protocols Mee...quirements Includes setup information for balanc...
...free plasmid DNA preparations are prepared from cu...m 1mg to multi-gram scales. Small-scale (1-100mg)...tions are made according to customer specification...stomer needs, and glycerol stocks are maintained t...
...rmones which belong to the transforming growth fac... large group of extra-cellular growth factors whic...e function and tumor formation (1). Other members ...differentiation factors, AMH/MIS (Anti-Mullerian H...
Biology Products: